🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Turkey / NCT07134049
Recruiting Not applicable

Sensory Integration Therapy in Children With Congenital Brachial Plexus Injury: Developmental Outcomes

NCT07134049 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2025-06-23
Last updated
2025-08-21

Condition(s) studied

Obstetric Brachial Plexus Injury

Investigational drug(s) / intervention(s)

sensory integration therapy

sensory integration therapy: Sensory Integration Therapy (SIT) is a client-centered rehabilitation approach aimed at improving adaptive and functional responses to sensory stimuli in changing environments. It is based on structured, individualized activities conducted in enriched sensory environments. These environments are designed to be engaging and motivating for children through the use of interactive and playful tasks that match their sensory processing profiles. Sensory integration plays a key role in motor planning, postural control, attention, and emotional regulation. Deficits in sensory integration-particularly in vestibular, tactile, and proprioceptive systems-may result in poor muscle tone, difficulty with balance and coordination, and impaired motor planning. These issues can negatively impact the development of gross motor, fine motor, language, and academic skills. For this reason, sensory-based interventions that support neural organization and promote adaptive responses are commonly recommended i

Study summary

The purpose of this study is to investigate the effectiveness of sensory integration therapy in reducing sensory, motor, and cognitive developmental impairments following Congenital Brachial Plexus Injury (CBPI), and to support the overall developmental processes of affected children.

Eligibility

Sex
ALL
Min age
7 Months
Max age
35 Months
Healthy volunteers
No
Inclusion Criteria: Confirmed diagnosis of obstetric brachial plexus injury (OBPI) Age between 7 and 35 months No additional diagnosed neurological, psychiatric, and/or muscular disorders No diagnosed mental retardation or cognitive disorder that would prevent participation in assessments Written informed consent from parents or legal guardians Exclusion Criteria: Severe visual or hearing impairment preventing participation in assessments Participation in another experimental rehabilitation program within the last 3 months

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hacettepe Univeristy Ankara Turkey (Türkiye) Recruiting

More Hacettepe University trials in Turkey

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07134049 on ClinicalTrials.gov ↗ ← All trials in Turkey